These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 16014060
1. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Mok CC, Tong KH, To CH, Siu YP, Au TC. Kidney Int; 2005 Aug; 68(2):813-7. PubMed ID: 16014060 [Abstract] [Full Text] [Related]
2. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan. Sakai R, Kurasawa T, Nishi E, Kondo T, Okada Y, Shibata A, Nishimura K, Chino K, Okuyama A, Takei H, Nagasawa H, Amano K. Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654 [Abstract] [Full Text] [Related]
3. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study. Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E. Lupus; 2007 Feb; 16(11):896-900. PubMed ID: 17971363 [Abstract] [Full Text] [Related]
4. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study. Mok CC, To CH, Yu KL, Ho LY. Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863 [Abstract] [Full Text] [Related]
5. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study. Fei Y, Wu Q, Zhang W, Chen H, Hou Y, Xu D, Li M, Zhang X, Zhao Y, Zeng X, Zhang F. Clin Exp Rheumatol; 2013 Oct; 31(1):62-8. PubMed ID: 22935463 [Abstract] [Full Text] [Related]
6. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis. Tanaka H, Aizawa T, Watanabe S, Oki E, Tsuruga K, Imaizumi T. Lupus; 2014 Jul; 23(8):813-8. PubMed ID: 24651669 [Abstract] [Full Text] [Related]
7. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome. Yap DY, Yu X, Chen XM, Lu F, Chen N, Li XW, Tang CS, Chan TM. Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934 [Abstract] [Full Text] [Related]
8. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice. Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K, Ito E. Nephron Clin Pract; 2012 May; 121(3-4):c165-73. PubMed ID: 23327881 [Abstract] [Full Text] [Related]
9. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose. Tanaka H, Oki E, Tsuruga K, Yashiro T, Hanada I, Ito E. Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719 [Abstract] [Full Text] [Related]
10. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria. Uchino A, Tsukamoto H, Nakashima H, Yoshizawa S, Furugo I, Mitoma H, Oryoji K, Shimoda T, Niiro H, Tada Y, Yano T, Nonaka T, Oishi R, Akashi K, Horiuchi T. Clin Exp Rheumatol; 2010 Dec; 28(1):6-12. PubMed ID: 20346231 [Abstract] [Full Text] [Related]
11. Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study. Wang S, Li X, Qu L, Wang R, Chen Y, Li Q, He X, Zhang X, Wang H, Wu J, Xu Y, Chen J. Lupus; 2012 Aug; 21(9):1025-35. PubMed ID: 22570338 [Abstract] [Full Text] [Related]
12. Long-term data on tacrolimus treatment in lupus nephritis. Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM. Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908 [Abstract] [Full Text] [Related]
13. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis. Szeto CC, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Gang W, Li PK. Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192 [Abstract] [Full Text] [Related]
14. Pulse cyclophospamide in severe lupus nephritis: Southern Indian experience. Das U, Dakshina Murty KV, Prasad N, Prayag A. Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):372-8. PubMed ID: 20228536 [Abstract] [Full Text] [Related]
15. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade. Tse KC, Lam MF, Tang SC, Tang CS, Chan TM. Lupus; 2007 Mar; 16(1):46-51. PubMed ID: 17283585 [Abstract] [Full Text] [Related]
16. Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis. Kagawa H, Hiromasa T, Hara T, Takaki A, Yamanaka R, Sada KE, Makino H. Clin Exp Nephrol; 2012 Oct; 16(5):760-6. PubMed ID: 22492013 [Abstract] [Full Text] [Related]
17. Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine. Chan TM, Tse KC, Tang CS, Lai KN, Li FK. Lupus; 2005 Oct; 14(4):265-72. PubMed ID: 15864912 [Abstract] [Full Text] [Related]
18. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC. Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783 [Abstract] [Full Text] [Related]
19. Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis. Lee T, Oh KH, Joo KW, Kim YS, Ahn C, Han JS, Kim S, Chin HJ. Lupus; 2010 Jul; 19(8):974-80. PubMed ID: 20581020 [Abstract] [Full Text] [Related]
20. Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis. Nomura A, Shimizu H, Kishimoto M, Suyama Y, Rokutanda R, Ohara Y, Yamaguchi K, Okada M. Lupus; 2012 Nov; 21(13):1444-9. PubMed ID: 22917589 [Abstract] [Full Text] [Related] Page: [Next] [New Search]